Search hospitals > North Carolina > Wilmington

Novo Nordisk Investigational Site

Claim this profile
Wilmington, North Carolina 28401
Global Leader in Type 2 Diabetes
Global Leader in Diabetes
Conducts research for Diabetes Mellitus
Conducts research for Obesity
Conducts research for Hemophilia
270 reported clinical trials
0 medical researchers
Photo of Novo Nordisk Investigational Site in WilmingtonPhoto of Novo Nordisk Investigational Site in WilmingtonPhoto of Novo Nordisk Investigational Site in Wilmington

Summary

Novo Nordisk Investigational Site is a medical facility located in Wilmington, North Carolina. This center is recognized for care of Type 2 Diabetes, Diabetes, Diabetes Mellitus, Obesity, Hemophilia and other specialties. Novo Nordisk Investigational Site is involved with conducting 270 clinical trials across 69 conditions. There are 0 research doctors associated with this hospital, such as .

Area of expertise

1Type 2 Diabetes
Global Leader
Novo Nordisk Investigational Site has run 133 trials for Type 2 Diabetes. Some of their research focus areas include:
Stage II
Stage I
2Diabetes
Global Leader
Novo Nordisk Investigational Site has run 122 trials for Diabetes.

Top PIs

Clinical Trials running at Novo Nordisk Investigational Site

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Novo Nordisk Investigational Site?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security